Related Experiment Video
Updated: May 16, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
Comparative study of the diffusion of five botulinum toxins type-A in five dosages of use: are there differences
Adilson Costa1, Elisangela Samartin Pegas Pereira, Margareth de Oliveira Pereira
1Pontifitial Catholic University of Campinas, Campinas/SP, Brazil.
Background:
Diffusion halo profiles of different commercially available type-A botulinum toxins (BTX-A) have been studied.
Objective:
To evaluate and compare the largest diameter of diffusion halos of 5 different doses of 5 different commercially available BTX-A.
Methods:
Twenty-five adult female volunteers were included. Products with 100 units (100 UI) and the product with 500 units (500 UI) were reconstituted in a ratio of 1:2.5. Products were applied in five different concentrations (1 U/2.5 U, 2 U/5 U, 3 U/7.5 U, 4 U/10 U, and 5 U/12.5 U). After 30 days, a starch-iodine test was conducted to obtain the largest diameter of each halo.
Results:
For all BTX-As, the higher the number of units used, the larger the diameter of the diffusion halo p<0.05). Statistically significant differences (p<0.05) were observed between the North American and Chinese BTX-As for the three lowest doses, between the Korean and German BTX-As for all doses, between the French and Chinese BTX-As for the four highest doses, between the French and German BTX-As for all doses, between the Chinese and German BTX-As for the four highest doses, and between the North American and German BTX-As for all doses (p<0.01).
Conclusions:
Differences were observed between all brands of BTX-As and between the different doses of each brand.
More Related Videos
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Bacterial Toxins
Bioequivalence studies: Biowaivers
Depolarizing Blockers: Pharmocokinetics
Bioavailability Study Design: Single Versus Multiple Dose Studies

